Telomir Research Development from 2010 to 2026
| TELO Stock | 1.07 0.05 4.46% |
Research Development | First Reported 2010-12-31 | Previous Quarter 2.6 M | Current Value 1.3 M | Quarterly Volatility 900.8 K |
Check Telomir Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Telomir Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.8 M, Selling General Administrative of 11.6 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 179. Telomir financial statements analysis is a perfect complement when working with Telomir Pharmaceuticals Valuation or Volatility modules.
Telomir | Research Development | Build AI portfolio with Telomir Stock |
Evaluating Telomir Pharmaceuticals's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Telomir Pharmaceuticals Common's fundamental strength.
Latest Telomir Pharmaceuticals' Research Development Growth Pattern
Below is the plot of the Research Development of Telomir Pharmaceuticals Common over the last few years. It is Telomir Pharmaceuticals' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Telomir Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Telomir Research Development Regression Statistics
| Arithmetic Mean | 714,813 | |
| Geometric Mean | 314,820 | |
| Coefficient Of Variation | 126.03 | |
| Mean Deviation | 761,356 | |
| Median | 126,492 | |
| Standard Deviation | 900,844 | |
| Sample Variance | 811.5B | |
| Range | 2.4M | |
| R-Value | 0.79 | |
| Mean Square Error | 321.6B | |
| R-Squared | 0.63 | |
| Significance | 0.0001 | |
| Slope | 141,418 | |
| Total Sum of Squares | 13T |
Telomir Research Development History
About Telomir Pharmaceuticals Financial Statements
Telomir Pharmaceuticals investors utilize fundamental indicators, such as Research Development, to predict how Telomir Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 2.6 M | 1.3 M |
Pair Trading with Telomir Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Telomir Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telomir Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Telomir Stock
| 0.87 | PG | Procter Gamble | PairCorr |
| 0.78 | VZ | Verizon Communications Aggressive Push | PairCorr |
| 0.71 | NVR | NVR Inc | PairCorr |
| 0.68 | JNJ | Johnson Johnson | PairCorr |
| 0.68 | PFE | Pfizer Inc Aggressive Push | PairCorr |
The ability to find closely correlated positions to Telomir Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Telomir Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Telomir Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Telomir Pharmaceuticals Common to buy it.
The correlation of Telomir Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Telomir Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Telomir Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Telomir Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Telomir Pharmaceuticals Correlation against competitors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Will Pharmaceuticals sector continue expanding? Could Telomir diversify its offerings? Factors like these will boost the valuation of Telomir Pharmaceuticals. If investors know Telomir will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Telomir Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Telomir Pharmaceuticals is measured differently than its book value, which is the value of Telomir that is recorded on the company's balance sheet. Investors also form their own opinion of Telomir Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Telomir Pharmaceuticals' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Telomir Pharmaceuticals' market value can be influenced by many factors that don't directly affect Telomir Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telomir Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Telomir Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Telomir Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.